GlassScriptPhysician profile
Meera Soni
NPI 1285165944
$1,359.06
in general payments reported to CMS, 2019-2025
21 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.14 · 2022: $167 · 2023: $383 · 2024: $607 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $502.04 | 2023-2025 | Qulipta, Rinvoq, Botox |
| Genentech USA, INC. | $149.18 | 2022-2024 | Ocrevus, Actemra, Enspryng |
| Lundbeck LLC | $129.18 | 2023-2025 | Vyepti, Rexulti |
| Sk Life Science, INC. | $74.17 | 2022-2024 | |
| Ucb, INC. | $72.28 | 2023-2024 | Zilbrysq |
| Janssen Biotech, INC. | $57.75 | 2023 | Tremfya |
| Emd Serono, INC. | $47.14 | 2021-2025 | |
| Glaxosmithkline, LLC. | $44.43 | 2023-2024 | Benlysta |
| Livanova USA, INC. | $35.29 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biogen, INC. | $29.46 | 2022-2025 | Vumerity |
| Mallinckrodt Hospital Products INC. | $26.50 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $23.75 | 2024 | |
| Amgen INC. | $23.23 | 2022 | |
| Aurinia Pharma U.S., INC. | $22.49 | 2024 | Lupkynis |
| Bayer Healthcare Pharmaceuticals INC. | $20.98 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $20.03 | 2022 | |
| Aucta Pharmaceuticals, INC. | $19.62 | 2025 | Motpoly Xr |
| Scilex Pharmaceuticals INC. | $18.69 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $17.44 | 2023 | Nuedexta |
| Kyowa Kirin, INC. | $13.18 | 2024 | Nourianz |
| Lilly USA, LLC | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meera Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.